- Home
- ASA vs TNDM Comparison
ASA vs TNDM Comparison
Compare ASA & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASA
- TNDM
- Stock Information
- Founded
- ASA 1958
- TNDM 2006
- Country
- ASA United States
- TNDM United States
- Employees
- ASA N/A
- TNDM N/A
- Industry
- ASA Precious Metals
- TNDM Medical/Dental Instruments
- Sector
- ASA Industrials
- TNDM Health Care
- Exchange
- ASA Nasdaq
- TNDM Nasdaq
- Market Cap
- ASA 945.7M
- TNDM 1.1B
- IPO Year
- ASA N/A
- TNDM 2013
- Fundamental
- Price
- ASA $45.68
- TNDM $13.40
- Analyst Decision
- ASA
- TNDM Buy
- Analyst Count
- ASA 0
- TNDM 16
- Target Price
- ASA N/A
- TNDM $21.56
- AVG Volume (30 Days)
- ASA 152.3K
- TNDM 1.8M
- Earning Date
- ASA 11-18-2025
- TNDM 11-06-2025
- Dividend Yield
- ASA 0.13%
- TNDM N/A
- EPS Growth
- ASA 335.96
- TNDM N/A
- EPS
- ASA 19.90
- TNDM N/A
- Revenue
- ASA $3,982,215.00
- TNDM $1,001,719,000.00
- Revenue This Year
- ASA N/A
- TNDM $8.27
- Revenue Next Year
- ASA N/A
- TNDM $9.63
- P/E Ratio
- ASA $2.29
- TNDM N/A
- Revenue Growth
- ASA 99.75
- TNDM 25.84
- 52 Week Low
- ASA $19.37
- TNDM $9.98
- 52 Week High
- ASA $53.76
- TNDM $38.28
- Technical
- Relative Strength Index (RSI)
- ASA 50.65
- TNDM 42.29
- Support Level
- ASA $44.00
- TNDM $13.66
- Resistance Level
- ASA $46.98
- TNDM $15.36
- Average True Range (ATR)
- ASA 1.64
- TNDM 0.79
- MACD
- ASA -0.45
- TNDM -0.19
- Stochastic Oscillator
- ASA 33.98
- TNDM 5.03
About ASA ASA Gold and Precious Metals Limited
ASA Gold And Precious Metals Ltd is a closed-end, non-diversified investment company. Its objective is to provide long-term capital appreciation through investing in companies engaged in the exploration for, development of projects, or mining of precious metals and minerals.
About TNDM Tandem Diabetes Care Inc.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.